Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!


Electrodiagnostic studies are an important component of the evaluation of patients with suspected peripheral nerve disorders. The evaluation of the patient with suspected peripheral neuropathy involves consideration of multiple sources of information, including the clinical history, neurologic examination, electrodiagnostic (EDX) studies, and laboratory studies. Key questions such as the pattern of weakness and temporal history of sensory loss should be elicited during the history and physical examination (Table 73–1).1,3

Table 73–1Approach to Neuropathic Disorders: Seven Key Questions

As an integral part of this comprehensive evaluation, electrodiagnostic studies can confirm and localize peripheral nerve disease, assess the type of nerve fiber involvement (motor and large sensory fibers), determine the distribution of nerve involvement, identify the underlying pathophysiologic process (axon loss, demyelination, or mixed features), determine the severity, and help monitor recovery or treatment effect (Fig. 73–1).

Figure 73–1

Approach to the evaluation of peripheral neuropathies. (CIDP = chronic inflammatory demyelinating polyradiculoneuropathy; EDx = electrodiagnostic; GBS = Guillain-Barré syndrome; IVIg = intravenous immunoglobulin) (Reproduced with permission from Amato AA, Barohn RJ. Peripheral Neuropathy. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J, eds. Harrison's Principles of Internal Medicine, 19e New York, NY: McGraw-Hill; 2014.)


The initial EDX studies in patients with suspected neuropathy should always include motor and sensory nerve conduction studies (NCSs) and needle electromyography (EMG) studies. The initial selection of nerves and muscles to study is guided by the clinical presentation of the individual patient. The NCSs are selected in the region of the patient's predominant clinical symptoms and pattern of involvement (Table 73–2).2

Table 73–2Patterns of Neuropathic Disorders

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.